Compound 48/80 increases murine bladder wall compliance independent of mast cells.
Compound 48/80 increases murine bladder wall compliance independent of mast cells.
复制标题
DOI:
10.1038/s41598-023-27897-6
复制
发表时间:
2023-01-12
影响因子:
4.6
通讯作者:
Tykocki NR
中科院分区:
文献类型:
--
作者:
Saxena P;Broemer E;Herrera GM;Mingin GC;Roccabianca S;Tykocki NR
A balance between stiffness and compliance is essential to normal bladder function, and changes in the mechanical properties of the bladder wall occur in many bladder pathologies. These changes are often associated with the release of basic secretagogues that in turn drive the release of inflammatory mediators from mast cells. Mast cell degranulation by basic secretagogues is thought to occur by activating an orphan receptor, Mas-related G protein-coupled receptor B2 (Mrgprb2). We explored the effects of the putative mast cell degranulator and Mrgprb2 agonist Compound 48/80 on urinary bladder wall mechanical compliance, smooth muscle contractility, and urodynamics, and if these effects were mast cell dependent. In wild-type mice, Mrgprb2 receptor mRNA was expressed in both the urothelium and smooth muscle layers. Intravesical instillation of Compound 48/80 decreased intermicturition interval and void volume, indicative of bladder overactivity. Compound 48/80 also increased bladder compliance while simultaneously increasing the amplitude and leading slope of transient pressure events during ex vivo filling and these effects were inhibited by the Mrgprb2 antagonist QWF. Surprisingly, all effects of Compound 48/80 persisted in mast cell-deficient mice, suggesting these effects were independent of mast cells. These findings suggest that Compound 48/80 degrades extracellular matrix and increases urinary bladder smooth muscle excitability through activation of Mrgprb2 receptors located outside of mast cells. Thus, the pharmacology and physiology of Mrgprb2 in the urinary bladder is of potential interest and importance in terms of treating lower urinary tract dysfunction.
登录
查看更多内容
影响因子:
4.5
作者:
Drake MJ;Kanai A;Bijos DA;Ikeda Y;Zabbarova I;Vahabi B;Fry CH
通讯作者:
Fry CH
影响因子:
7.3
作者:
Dondalska A;Rönnberg E;Ma H;Pålsson SA;Magnusdottir E;Gao T;Adam L;Lerner EA;Nilsson G;Lagerström M;Spetz AL
通讯作者:
Spetz AL
影响因子:
2.7
作者:
Fitzgerald, Jocelyn J.;Ustinova, Elena;Koronowski, Kevin B.;de Groat, William C.;Pezzone, Michael A.
通讯作者:
Pezzone, Michael A.
DOI:
10.1016/j.jaci.2016.12.980
发表时间:
2017-08
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Azimi E;Reddy VB;Pereira PJS;Talbot S;Woolf CJ;Lerner EA
通讯作者:
Lerner EA
影响因子:
7.8
作者:
HINEK, A;RABINOVITCH, M
通讯作者:
RABINOVITCH, M